1. CMU Intellectual Repository

Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 15 (Search time: 0.003 seconds).
Item hits:
Issue DateTitleAuthor(s)
1-Sep-2013Five-year trends in antiretroviral usage and drug costs in HIV-infected children in ThailandIntira Collins; John Cairns; Sophie Le Coeur; Karin Pagdi; Chaiwat Ngampiyaskul; Prapaisri Layangool; Thitiporn Borkird; Sathaporn Na-Rajsima; Vanichaya Wanchaitanawong; Gonzague Jourdain; Marc Lallemant
1-Oct-2010Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in ThailandNelly Briand; Sophie Le Coeur; Gonzague Jourdain; Somboon Hotrawarikarn; Surat Sirinontakan; Temsiri Hinjiranandana; Suparat Kanjanavanit; Patrinee Traisathit; Kenneth McIntosh; Marc Lallemant
24-Sep-2012Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapyIntira J. Collins; John Cairns; Gonzague Jourdain; Federica Fregonese; Maneeratn Nantarukchaikul; Narong Lertpienthum; Pornpun Wannarit; Pornsawan Attavinijtrakarn; Prapaisri Layangool; Sophie Le Coeur; Marc Lallemant
1-Jan-2016Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancyPatumrat Sripan; Sophie Le Coeur; Lily Ingsrisawang; Tim R. Cressey; Naïm Bouazza; Frantz Foissac; Nicole Ngo-Giang-Huong; Patrinee Traisathit; Ussanee Srirompotong; Orada Patamasingh Na Ayudhaya; Achara Puangsombat; Jantana Jungpipun; Kanokwan Jittayanun; Jean Marc Tréluyer; Gonzague Jourdain; Marc Lallemant; Saïk Urien
1-Jan-2016A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based RegimensNontiya Homkham; Tim R. Cressey; Lily Ingsrisawang; Naïm Bouazza; Chaiwat Ngampiyaskul; Suchat Hongsiriwon; Sakulrat Srirojana; Suparat Kanjanavanit; Sorakij Bhakeecheep; Sophie Le Coeur; Nicolas Salvadori; Jean Marc Treluyer; Gonzague Jourdain; Saik Urien
17-May-2018Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian StudiesShino Arikawa; Nigel Rollins; Gonzague Jourdain; Jean Humphrey; Athena P. Kourtis; Irving Hoffman; Max Essex; Tim Farley; Hoosen M. Coovadia; Glenda Gray; Louise Kuhn; Roger Shapiro; Valériane Leroy; Robert C. Bollinger; Carolyne Onyango-Makumbi; Shahin Lockman; Carina Marquez; Tanya Doherty; François Dabis; Laurent Mandelbrot; Sophie Le Coeur; Matthieu Rolland; Pierre Joly; Marie Louise Newell; Renaud Becquet
1-Jan-2015New-onset diabetes and antiretroviral treatments in HIV-infected adults in ThailandPrakit Riyaten; Nicolas Salvadori; Patrinee Traisathit; Nicole Ngo-Giang-Huong; Tim R. Cressey; Prattana Leenasirimakul; Malee Techapornroong; Chureeratana Bowonwatanuwong; Pacharee Kantipong; Ampaipith Nilmanat; Naruepon Yutthakasemsunt; Apichat Chutanunta; Suchart Thongpaen; Virat Klinbuayaem; Luc Decker; Sophie Le Coeur; Marc Lallemant; Jacqueline Capeau; Jean Yves Mary; Gonzague Jourdain
1-Jan-2015Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in ThailandMarc Lallemant; Sophie Le Coeur; Wasna Sirirungsi; Tim R. Cressey; Nicole Ngo-Giang-Huong; Patrinee Traisathit; Virat Klinbuayaem; Prapan Sabsanong; Prateep Kanjanavikai; Gonzague Jourdain; Kenneth McIntosh; Suporn Koetsawang
1-Jun-2017Incidence of tuberculosis and associated mortality in a cohort of human immunodeficiency virus-infected children initiating antiretroviral therapyNicolas Salvadori; Nicole Ngo-Giang-Huong; Chloé Duclercq; Suparat Kanjanavanit; Chaiwat Ngampiyaskul; Pornchai Techakunakorn; Achara Puangsombat; Julie Figoni; Jean Yves Mary; Intira J. Collins; Tim R. Cressey; Sophie Le Coeur; Wasna Sirirungsi; Marc Lallemant; Kenneth McIntosh; Gonzague Jourdain
15-Aug-2017Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for NeonatesTim R. Cressey; Baralee Punyawudho; Sophie Le Coeur; Gonzague Jourdain; Chalermpong Saenjum; Edmund V. Capparelli; Kanokwan Jittayanun; Siriluk Phanomcheong; Anita Luvira; Thitiporn Borkird; Achara Puangsombat; Leon Aarons; Pra Ornsuda Sukrakanchana; Saik Urien; Marc Lallemant; Suraphan Sangsawang; Jullapong Achalapong; Kanchana Preedisripipat; Chaiwat Putiyanun; Vanichaya Wanchaitanawong; Prapap Yuthavisuthi; Chaiwat Ngampiyaskul; Prateep Kanjanavikai; Nantasak Chotivanich; Suchat Hongsiriwon; Weerapong Suwankornsakul; Phantip Sreshthatat; Annop Kanjanasing; Ratchanee Kwanchaipanich; Boonsong Rawangban; Sadhit Santadusit; Tapnarong Jarupanich; Boonyarat Warachit; Thitiporn Siriwachirachai; Pornpimon Rojanakarin; Kraisorn Vivatpatanakul; Sansanee Hanpinitsak; Phaiboon Wanasiri; Sakulrat Srirojana; Rucha Kongpanichkul; Suthunya Bunjongpak; Prapan Sabsanong; Prateung Liampongsabuddhi; Kultida Pongdetudom; Prayoon Khamja; Noppadon Akarathum; Supha Arth Phonin; Wannee Limpitikul; Jantana Jungpipun; Ratikorn Petprakorp; Sukit Mahattanan; Somsri Kotchawet; Toranong Pilalai

Discover